Martin, L., Alibhai, S., Komisarenko, M., Timilshina, N., & Finelli, A. (2018). Identification of subgroups of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone plus prednisone at low- vs. high-risk of radiographic progression: An analysis of COU-AA-302. Canadian Urological Association Journal, 13(6). https://doi.org/10.5489/cuaj.5586